Geron News

Geron Corporation today announced that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has granted Geron's request to declare an interference between a patent application owned by Geron and U.S. Patent No.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Dec 8, 2009 - Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia at the 51st Annual Meeting of the American Society of Hematology in New Orleans, Louisiana.

Several stocks trading under $10 were poised to move on above-average volume during Tuesday's session.

Several stocks trading near $5 were moving on above-average volume during Wednesday's session.

Emerging Healthcare Solutions, Inc. today announced the Company has entered into discussions with a Houston-based medical company relating to its patented, and patent pending, genetics technologies.

Geron is the company that made news withA its stem cell therapy showing benefits in treating spine injuries in rodents' cervical region.

In this file photo originally made available by Advanced Cell Technology in 2006, a single cell is removed from a human embryo to be used in generating embryonic stem cells for scientific research.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Nov 19, 2009 - Geron Corporation today announced the presentation of interim data from its ongoing trial of imetelstat , a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.

The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials.

Nov 11, 2009 - Geron Corporation today announced the publication of data showing that oligodendrocyte progenitor cells derived from human embryonic stem cells , when transplanted into a rodent model of cervical spinal cord injury, reduced tissue damage within the lesion and improved recovery of locomotor function.

News that the Wake Forest Institute for Regenerative Medicine has successfully grown rabbit penises in a lab set off a media feeding frenzy .

Geron Corporation is a company based in Menlo Park, CA and the first biotech company in the USA to be granted permission for a clinical trial of regenerative medicine using embryonic stem cells, in humans.

Geron Corp. surged right out of the gate Friday morning, as traders cheered the stem cell stock's narrower-than-expected quarterly loss .

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Hey there, Fools. I've summoned our Motley Fool CAPS community once again to highlight a few of Monday's biggest winners among the stocks with top ratings of four or five stars: There's a reason I selected those notable gainers, as opposed to other winners making noise on Monday, like low-rated biotech Geron : Stocks go up all the time, but unless ...

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." So you might think we'd be the last people to give virtual ink to such "news." And we would be -- if that were all we were doing.

First, who are the Nobel Prize winners? Why is their research so important in the areas of aging and cancer detection? Three Americans won the Nobel Prize for medicine.

In the Lightning Round, Cramer was bullish on Citigroup , Urban Outfitters , Wal-Mart , Celgene , Gilead Sciences , Energy Transfer Partners , Dow Chemical and PPG Industries .